Sage Journals: Discover world-class research

Abstract

Many mutations in the human rhodopsin gene (RHO) cause autosomal dominant retinitis pigmentosa (ADRP). Our previous studies with a P23H (proline-23 substituted by histidine) RHO transgenic mouse model of ADRP demonstrated significant improvement of retinal function and preservation of retinal structure after transfer of wild-type rhodopsin by AAV. In this study we demonstrate long-term rescue of retinal structure and function by a single virus expressing both RHO replacement cDNA and small interfering RNA (siRNA) to digest mouse Rho and human P23H RHO mRNA. This combination should prevent overexpression of rhodopsin, which can be deleterious to photoreceptors. On the basis of the electroretinogram (ERG) response, degeneration of retinal function was arrested at 2 months postinjection, and the response was maintained at this level until termination at 9 months. Preservation of the ERG response in P23H RHO mice reflected survival of photoreceptors: both the outer nuclear layer (ONL) and outer segments of photoreceptor cells maintained the same thickness as in nontransgenic mice, whereas the control injected P23H eyes exhibited severe thinning of the ONL and outer segments. These findings suggest that delivery of both a modified cDNA and an siRNA by a single adeno-associated viral vector provided long-term rescue of ADRP in this model. Because the siRNA targets human as well as mouse rhodopsin mRNAs, the combination vector may be useful for the treatment of human disease.

Get full access to this article

View all access options for this article.

References

Cao

, Wen

, Li

et al. 1997. Mechanical injury increases bFGF and CNTF mRNA expression in the mouse retina. Exp. Eye Res., 65:241–248.

Cashman

S.M.

, Binkley

E.A.

, Kumar-Singh

2005. Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference. Gene Ther., 12:1223–1228.

Chadderton

, Millington-Ward

, Palfi

et al. 2009. Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy. Mol. Ther., 17:593–599.

Daiger

S.P.

, Bowne

S.J.

, Sullivan

L.S.

2007. Perspective on genes and mutations causing retinitis pigmentosa. Arch. Ophthalmol., 125:151–158.

Dryja

T.P.

, McGee

T.L.

, Reichel

et al. 1990. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature, 343:364–366.

Flannery

J.G.

, Zolotukhin

, Vaquero

M.I.

et al. 1997. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A., 94:6916–6921.

Frederick

J.M.

, Krasnoperova

N.V.

, Hoffmann

et al. 2001. Mutant rhodopsin transgene expression on a null background. Invest. Ophthalmol. Vis. Sci., 42:826–833.

Georgiadis

, Tschernutter

, Bainbridge

J.W.

et al. 2011. AAV-mediated knockdown of peripherin-2 in vivo using miRNA-based hairpins. Gene Ther., 17:486–493.

Gorbatyuk

M.S.

, Pang

J.J.

, Thomas

et al. 2005. Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach. Mol. Vis., 11:648–656.

10.

Gorbatyuk

, Justilien

, Liu

et al. 2007a. Preservation of photoreceptor morphology P23H rats using an allele independent and function in ribozyme. Exp. Eye Res., 84:44–52.

11.

Gorbatyuk

, Justilien

, Liu

et al. 2007b. Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery. Vis. Res., 47:1202–1208.

12.

Gorbatyuk

M.S.

, Hauswirth

W.W.

, Lewin

A.S.

2008. Gene therapy for mouse models of ADRP. Adv. Exp. Med. Biol., 613:107–112.

13.

Gorbatyuk

M.S.

, Knox

, Lavail

M.M.

et al. 2010. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proc. Natl. Acad. Sci. U.S.A., 107:5961–5966.

14.

Hartong

D.T.

, Berson

E.L.

, Dryja

T.P.

2006. Retinitis pigmentosa. Lancet, 368:1795–1809.

15.

Huber

, Beck

S. C.

, Grimm

et al. 2009. Spectral domain optical coherence tomography in mouse models of retinal degeneration. Invest. Ophthalmol. Vis. Sci., 50:5888–5895.

16.

Kaushal

, Khorana

H.G.

1994. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry, 33:6121–6128.

17.

Kiang

A.S.

, Palfi

, Ader

et al. 2005. Toward a gene therapy for dominant disease: Validation of an RNA interference-based mutation-independent approach. Mol. Ther., 12:555–561.

18.

Laemmli

U.K.

1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680–685.

19.

Lem

, Krasnoperova

N.V.

, Calvert

P.D.

et al. 1999. Morphological, physiological, and biochemical changes in rhodopsin knockout mice. Proc. Natl. Acad. Sci. U.S.A., 96:736–741.

20.

Lewin

A.S.

, Drenser

K.A.

, Hauswirth

W.W.

et al. 1998. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat. Med., 4:967–971.

21.

, Xiao

, Gray

S.J.

et al. 2011. Combination therapy utilizing shRNA knockdown and an optimized resistant transgene for rescue of diseases caused by misfolded proteins. Proc. Natl. Acad. Sci. U.S.A., 108:14258–14263.

22.

Lin

J.H.

, Li

, Yasumura

et al. 2007. IRE1 signaling affects cell fate during the unfolded protein response. Science, 318:944–949.

23.

Mao

, James

Jr. , Schwein

et al. 2011. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa. Hum. Gene Ther., 22:567–575.

24.

Mendes

H.F.

, van der Spuy

, Chapple

J.P.

, Cheetham

M.E.

2005. Mechanisms of cell death in rhodopsin retinitis pigmentosa: Implications for therapy. Trends Mol. Med., 11:177–185.

25.

Millington-Ward

, Chadderton

, O'Reilly

et al. 2011. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa. Mol. Ther., 19:642–649.

26.

Morris

M.B.

, Dastmalchi

, Church

W.B.

2009. Rhodopsin: Structure, signal transduction and oligomerisation. Int. J. Biochem. Cell Biol., 41:721–724.

27.

Mueller

, Tang

, Gruntman

et al. 2012. Sustained miRNA-mediated knockdown of mutant AAT with simultaneous augmentation of wild-type AAT has minimal effect on global liver miRNA profiles. Mol. Ther., 20:590–600.

28.

Mussolino

, Sanges

, Marrocco

et al. 2011. Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa. EMBO Mol. Med., 3:118–128.

29.

Noorwez

S.M.

, Kuksa

, Imanishi

et al. 2003. Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J. Biol. Chem., 278:14442–14450.

30.

Noorwez

S.M.

, Malhotra

, McDowell

J.H.

et al. 2004. Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H. J. Biol. Chem., 279:16278–16284.

31.

Olsson

J.E.

, Gordon

J.W.

, Pawlyk

B.S.

et al. 1992. Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa. Neuron, 9:815–830.

32.

O'Reilly

, Palfi

, Chadderton

et al. 2007. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am. J. Hum. Genet., 81:127–135.

33.

Phelan

J.K.

, Bok

2000. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol. Vis., 6:116–124.

34.

Sakami

, Maeda

, Bereta

et al. 2011. Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations. J. Biol. Chem., 286:10551–10567.

35.

Saliba

R.S.

, Munro

P.M.

, Luthert

P.J.

, Cheetham

M.E.

2002. The cellular fate of mutant rhodopsin: Quality control, degradation and aggresome formation. J. Cell Sci., 115:2907–2918.

36.

Smith

A.J.

, Bainbridge

J.W.

, Ali

R.R.

2009. Prospects for retinal gene replacement therapy. Trends Genet., 25:156–165.

37.

Sullivan

J.M.

, Pietras

K.M.

, Shin

B.J.

, Misasi

J.N.

2002. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa. Mol. Vis., 8:102–113.

38.

Sung

C.H.

, Makino

, Baylor

, Nathans

1994. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment. J. Neurosci., 14:5818–5833.

39.

Tam

B.M.

, Moritz

O.L.

2006. Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci., 47:3234–3241.

40.

Tan

, Wang

, Quiambao

A.B.

et al. 2001. The relationship between opsin overexpression and photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci., 42:589–600.

41.

Timmers

A.M.

, Zhang

, Squitieri

, Gonzalez-Pola

2001. Subretinal injections in rodent eyes: Effects on electrophysiology and histology of rat retina. Mol. Vis., 7:131–137.

42.

Wilson

J.H.

, Wensel

T.G.

2003. The nature of dominant mutations of rhodopsin and implications for gene therapy. Mol. Neurobiol., 28:149–158.

43.

T.H.

, Ting

T.D.

, Okajima

T.I.

et al. 1998. Opsin localization and rhodopsin photochemistry in a transgenic mouse model of retinitis pigmentosa. Neuroscience, 87:709–717.

44.

Zolotukhin

, Potter

, Zolotukhin

et al. 2002. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods, 28:158–167.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.27 MB

Long-Term Rescue of Retinal Structure and Function by Rhodopsin RNA Replacement with a Single Adeno-Associated Viral Vector in P23H RHO Transgenic Mice

Abstract

Get full access to this article

References

Supplementary Material